CAS: 362-74-3; (4Ar,6R,7R,7Ar)-6-(6-Butyramido-9H-Purin-9-yl)-2-Hydroxy-2-Oxidotetrahydro-4H-Furo[3,2-D][1,3,2]Dioxaphosphinin-7-Yl Butyrate

该化合物是细胞信号中最重要的第二个发信人,其特征是细胞信号中循环环氧乙酸单磷(CAMP)合成衍生物,其特点是,与dene modie的氮原子相连的两个丁基烯组的存在,与cAMP相比,它增加了其膜透视性.这一修改允许二丁基丙基丙基氨基苯(CAS 362-74-3)有效穿透细胞膜并激活细胞内信号路径.它通常用于生物化学研究,以研究丙基苯丙胺在各种生理过程中的作用,包括细胞生长,分化和代谢作用.该化合物一般为白色至白色粉末,在水和有机溶剂中溶解.在生理条件下,其稳定性使其成为药理学研究的一个宝贵工具.丁基丙基丙基丙基苯可以激活蛋白体A(PKA)并影响各种下游效应,使其在信号传导机制的调查中具有重大意义.但是,与所有化学物质一样,应当谨慎处理,在实验室中遵循适当的安全规定.

结构式图片

上下游产品

butanoic acid anhydride cAMP

合成工艺路线路线简述

    丁酸酐,腺苷环磷酸酯置于n,N-二异丙基乙胺体系中,用 N,N-二甲基甲酰胺 作为反应溶剂,化学反应 7.0H,以96.09%的收率获得产物二丁酰环磷腺苷
    参考文献:一种二丁酰环磷腺苷类化合物及其金属盐的制备方法
    标题:一种二丁酰环磷腺苷类化合物及其金属盐的制备方法
    摘要:本发明公开了一种二丁酰环磷腺苷类化合物及其金属盐的制备方法.其中,二丁酰环磷腺苷类化合物的制备方法包括以下步骤:非质子溶剂中,在有机碱存在下,所述的如式i所示的环磷腺苷与正丁酸酐进行如下所示的酰化反应得二丁酰环磷腺苷类化合物,所述的二丁酰环磷腺苷类化合物的阴离子如式ii所示,其中,所述的二丁酰环磷腺苷类化合物的阳离子为h

    海关参考信息

    专利信息


    专利号:US-6372721-B1
    优先权日:1993-12-17
    标题:Method for inducing DNA synthesis in neurons
    发明人:NEUMAN TOOMAS; SUDA KIKUO; NORNES HOWARD O
    权利人:SPINAL CORD SOC
    摘要:A method is provided for inducing DNA synthesis in differentiated neurons. According to certain embodiments of the invention, a method for inducing DNA synthesis in a differentiated neuron is provided that includes obtaining a vector comprising nucleic acid encoding an E2F regulator and/or an E1A regulator, wherein the vector can be used to express the nucleic acid in a differentiated neuron, and transfecting a differentiated neuron with the vector. According to certain embodiments of the invention, a method for integrating DNA encoding a desired protein in a differentiated neuron is provided that includes obtaining a vector comprising nucleic acid encoding an E2F regulator and/or an E1A regulator, wherein the vector can be used to express the nucleic acid in a neuron, obtaining DNA encoding a desired protein, and cotransfecting a differentiated neuron with the vector and the DNA encoding the desired protein such that the DNA encoding the desired protein is integrated in the differentiated neuron and the desired protein is produced.

    专利号:US-4780406-A
    优先权日:1983-10-18
    标题:Flow cytometric measurement of total DNA and incorporated halodeoxyuridine
    发明人:DOLBEARE FRANK A; GRAY JOE W
    权利人:UNIV CALIFORNIA
    摘要:A method for the simultaneous flow cytometric measurement of the total DNA content and the level of DNA synthesis in normal and malignant cells is disclosed. The sensitivity of the method allows a study of cell cycle traverse rates for large scale cell populations as well as single cell measurements. A DNA stain such as propidium iodide or Hoechst 33258 is used as the probe for the measurement of total DNA content and a monoclonal antibody reactive with a DNA precursor such as halodeoxy-uridine (HdU), more specifically bromodeoxyuridine (BrdU) is used as a probe for the measurement of HdU or BrdU uptake by the cells as a measure of DNA synthesis.

    专利号:US-4609622-A
    优先权日:1983-05-31
    标 题:Clinical determination and/or quantification of thyrotropin and a variety of thyroid stimulatory or inhibitory factors performed in vitro with an improved thyroid cell line, FRTL-5
    发明人:KOHN LEONARD D; VALENTE WILLIAM A; GROLLMAN-WOLFF EVELYN F; ALOJ SALVATORE M; VITTI PAOLO
    权利人:INTERTHYR RESEARCH FOUNDATION; UNIV MARYLAND
    摘要:A fast growing, continuous, functional rat thyroid cell strain, FRTL-5, which maintains functional characteristics of iodide uptake and thyroglobulin synthesis over prolonged periods of culture is cloned from FRTL cells obtained from primary cultures of Fischer rat thyroid glands. The FRTL-5 cells are cultured in a medium containing approximately 5 percent calf serum supplemented with a mixture of hormones, at least one of which is thyrotropin. n The FRTL-5 cells are employed in a series of assays which measure thyroid stimulatory or inhibitory factors. The FRTL-5 system of assay specifically measures thymidine incorporation, cAMP elevation and iodide uptake and permits the evaluation of patient sera, particularly those afflicted with Graves' disease and other autoimmune thyroid diseases, thereby providing a means for determining appropriate methods of treatment.

    专利号:US-5554359-A
    优先权日:1989-12-15
    标 题:Pigmentation enhancer and method
    发明人:FULLER BRYAN B
    权利人:UNIV OKLAHOMA
    摘要:A composition comprising a lysosomotropic agent, and optionally phosphodiesterase inhibitors, and/or methylxanthines for increasing synthesis of melanin in a human melanocyte thereby enhancing pigmentation of the human skin. Use of this composition promotes tanning of the human skin and increases photoprotection from ultraviolet radiation. An organ culture system comprising viable human foreskin samples which may be used to test the effects of agents on human skin, including pigmentation enhancers on human skin.

    专利号:US-4608341-A
    优先权日:1983-05-31
    标 题:Living, fast-growing thyroid cell strain, FRTL-5
    发明人:AMBESI-IMPIOMBATO FRANCESCO S
    权利人:INTERTHYR RESEARCH FOUNDATION
    摘要:A fast growing, continuous, functional rat thyroid cell strain, FRTL-5, which maintains functional characteristics of iodide uptake and thyroglobulin synthesis over prolonged periods of culture is cloned from FRTL cells obtained from primary cultures of Fischer rat thyroid glands. The FRTL-5 cells are cultured in a medium containing approximately 5 percent calf serum supplemented with a mixture of hormones, at least one of which is thyrotropin. The FRTL-5 cells are employed in a series of assays which measure thyroid stimulatory or inhibitory factors. The FRTL-5 system of assay specifically measures thymidine incorporation, cAMP elevation and iodide uptake and permits the evaluation of patient sera, particularly those afflicted with Graves' disease and other autoimmune thyroid diseases, thereby providing a means for determining appropriate methods of treatment.

    专利号:WO-2004046348-A1
    优先权日:2002-11-17
    标题:Methods, nucleic acid constructs and cells for treating neurodegenerative disorders
    发明人:OFFEN DANIEL; MELAMED ELDAD; LEVY YOSEF
    权利人:UNIV RAMOT; OFFEN DANIEL; MELAMED ELDAD; LEVY YOSEF
    摘要:A method of treating a neurodegenerative disorder is provided. The method is effected by administering to an individual in need thereof cells capable of exogenously regulatable neurotransmitter synthesis thereby treating the neurodegenerative disorder.
    开平牵牛生化制药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.genuine.com.cn
    电话: 0750-2882278👤
    📞开平牵牛生化制药有限公司 ⚠️参考联系方式

    销售电话:0750-2882278
    邮箱:xiaozy@genuine.com.cn
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    杭州乾弼贸易有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.qianbi-bio.com
    电话: 0571-85812783👤
    📞杭州乾弼贸易有限公司 ⚠️参考联系方式

    销售电话:0571-85812783
    邮箱:info@qianbi-bio.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    杭州美亚药业股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.meiyapharm.com
    电话: 0571-88091583👤
    📞杭州美亚药业股份有限公司 ⚠️参考联系方式

    销售电话:0571-88091583
    邮箱:sales@meiyapharm.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Tabrizian K, Hashemzaei M, Nasiri AA, Najafi S, Amelinia F, Sanati M, Shamshirgaran F, Fanoudi S. Interactive involvement of hippocampal cAMP/PKA and cyclooxygenase-2 signaling pathways in spatial learning in the Morris water maze. Folia Neuropathol. 2018;56(1):58-66. doi: 10.5114/fn.2018.74660. doi: 10.1016/j.brainresbull.2018.03.016. [Epub ahead of print] doi: 10.1016/j.lfs.2017.11.040. Epub 2017 Nov 26. doi: 10.1016/j.jphs.2017.09.032. Epub 2017 Oct 6. doi: 10.1016/j.jphs.2017.09.001. Epub 2017 Sep 8. doi: 10.1002/jcb.26321. Epub 2017 Sep 28. doi: 10.1016/j.virol.2017.07.023. Epub 2017 Jul 24. doi: 10.1111/febs.14166. Epub 2017 Aug 8. doi: 10.1074/jbc.M117.800391. Epub 2017 Jun 27.
    10: Flores-Sandoval O, Sánchez-Briones ME, López-Rodríguez JF, Calvo-Turrubiartes MZ, Llamazares-Azuara L, Rodríguez-Martínez M. Highly suggestive preliminary evidence that the renal interstitium contracts in vivo. Physiol Rep. 2017 Jun;5(12). pii: e13328. doi: 10.14814/phy2.13328.
    11: Kong D, Cui J, Fu J. DbcAMP regulates adipogenesis in sheep inguinal preadipocytes. Lipids Health Dis. 2017 May 19;16(1):93. doi: 10.1186/s12944-017-0478-6.

    合成参考文献


    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知